Annual EBITDA
$4.08B$195.00M+5.01%
Summary
- Current Value
- As of today, ZTS annual EBITDA is $4.08B, up +5.01% on
- Historical Performance
- ZTS annual EBITDA is up +20.37% over the past 3 years, up +50.70% over the past 5 years
- All-Time High Comparison
- ZTS annual EBITDA is currently at its all-time high
- 3-Year Low Comparison
- ZTS annual EBITDA is +20.37% above its 3-year low of $3.39B reached on an earlier date
- Sector Comparison
- ZTS annual EBITDA is higher than 97.33% of companies in Healthcare sector
EBITDA Chart
SUGGESTED SERIES
Performance
| Metric | Date | Value | 1Y | 3Y | 5Y | 15Y |
|---|---|---|---|---|---|---|
| Annual EBITDA | $4.08B | +5.0% | +20.4% | +50.7% | +726.7% | |
| Quarterly EBITDA | $941.00M | +1.1% | +11.0% | +8.9% | +368.2% | |
| TTM EBITDA | $4.06B | +4.3% | +21.6% | +38.8% | +1919.9% | |
| Price | $79.71 | -50.6% | -55.6% | -54.7% | – | |
| PE Ratio | 13.21 | -55.0% | -67.4% | -72.2% | – | |
| Annual Revenue | $9.47B | +2.3% | +17.2% | +41.8% | +164.3% | |
| Annual EPS | $6.02 | +10.2% | +34.0% | +76.0% | +2637.5% | |
| $3.60B | +6.0% | +22.9% | +58.5% | +1064.1% | ||
| Annual Net Income | $2.67B | +7.1% | +26.6% | +63.4% | +2308.1% |
EBITDA Highs
| Period | High | Date | Current |
|---|---|---|---|
| 3Y | $4.08B | at high | |
| 5Y | $4.08B | at high | |
| All | $4.08B | at high |
EBITDA Lows
| Period | Low | Date | Current |
|---|---|---|---|
| 3Y | $3.39B | N/A | +20.4% |
| 5Y | $2.71B | N/A | +50.7% |
| All | $405.00M | +908.4% |
EBITDA History
FAQ
What is the current annual EBITDA of ZTS?
As of today, ZTS annual EBITDA is $4.08B
What is 1-year change in ZTS annual EBITDA?
ZTS annual EBITDA is up +5.01% year-over-year
What is 3-year change in ZTS annual EBITDA?
ZTS annual EBITDA is up +20.37% over the past 3 years
How far is ZTS annual EBITDA from its all-time high?
ZTS annual EBITDA is currently at its all-time high
How does ZTS annual EBITDA rank versus sector peers?
ZTS annual EBITDA is higher than 97.33% of companies in Healthcare sector
When is ZTS next annual earnings release?
As of today, the next annual earnings release for ZTS has not been scheduled
Quarterly EBITDA
$941.00M$6.00M-0.63%
Summary
- Current Value
- As of today, ZTS quarterly EBITDA is $941.00M, down -0.63% on
- Historical Performance
- ZTS quarterly EBITDA is up +1.07% year-over-year, up +10.97% over the past 3 years
- All-Time High Comparison
- ZTS quarterly EBITDA is currently -15.38% below its historical high of $1.11B set on
- 3-Year Low Comparison
- ZTS quarterly EBITDA is +12.69% above its 3-year low of $835.00M reached on
- Sector Comparison
- ZTS quarterly EBITDA is higher than 96.68% of companies in Healthcare sector
Performance
| Metric | Date | Value | 3M | 1Y | 3Y | 5Y |
|---|---|---|---|---|---|---|
| Quarterly EBITDA | $941.00M | -0.6% | +1.1% | +11.0% | +8.9% | |
| Annual EBITDA | $4.08B | – | +5.0% | +20.4% | +50.7% | |
| TTM EBITDA | $4.06B | +0.3% | +4.3% | +21.6% | +38.8% | |
| Price | $79.71 | -38.1% | -50.6% | -55.6% | -54.7% | |
| PE Ratio | 13.21 | -38.9% | -55.0% | -67.4% | -72.2% | |
| Quarterly Revenue | $2.26B | -5.2% | +2.9% | +13.1% | +20.9% | |
| Quarterly EPS | $1.42 | +3.5% | +5.9% | +19.8% | +21.6% | |
| $822.00M | -0.5% | +1.2% | +12.9% | +8.9% | ||
| Quarterly Net Income | $601.00M | -0.3% | -0.2% | +9.1% | +7.7% |
Quarterly EBITDA Highs
| Period | High | Date | Current |
|---|---|---|---|
| 1Y | $1.11B | -15.4% | |
| 3Y | $1.11B | -15.4% | |
| 5Y | $1.11B | -15.4% | |
| All | $1.11B | -15.4% |
Quarterly EBITDA Lows
| Period | Low | Date | Current |
|---|---|---|---|
| 1Y | $931.00M | N/A | +1.1% |
| 3Y | $835.00M | +12.7% | |
| 5Y | $713.00M | +32.0% | |
| All | $191.00M | +392.7% |
Quarterly EBITDA History
FAQ
What is the current quarterly EBITDA of ZTS?
As of today, ZTS quarterly EBITDA is $941.00M
What is ZTS quarterly EBITDA most recent change?
ZTS quarterly EBITDA was down -0.63% on March 31, 2026
What is 1-year change in ZTS quarterly EBITDA?
ZTS quarterly EBITDA is up +1.07% year-over-year
How far is ZTS quarterly EBITDA from its all-time high?
ZTS quarterly EBITDA is currently -15.38% below its historical high of $1.11B set on June 30, 2025
How does ZTS quarterly EBITDA rank versus sector peers?
ZTS quarterly EBITDA is higher than 96.68% of companies in Healthcare sector
When is ZTS next earnings release?
The next earnings release for ZTS is on
TTM EBITDA
$4.06B$10.00M+0.25%
Summary
- Current Value
- As of today, ZTS TTM EBITDA is $4.06B, up +0.25% on
- Historical Performance
- ZTS TTM EBITDA is up +4.29% year-over-year, up +21.63% over the past 3 years
- All-Time High Comparison
- ZTS TTM EBITDA is currently at its all-time high
- 3-Year Low Comparison
- ZTS TTM EBITDA is +21.63% above its 3-year low of $3.34B reached on an earlier date
- Sector Comparison
- ZTS TTM EBITDA is higher than 96.86% of companies in Healthcare sector
Performance
| Metric | Date | Value | 3M | 1Y | 3Y | 5Y |
|---|---|---|---|---|---|---|
| TTM EBITDA | $4.06B | +0.3% | +4.3% | +21.6% | +38.8% | |
| Annual EBITDA | $4.08B | – | +5.0% | +20.4% | +50.7% | |
| Quarterly EBITDA | $941.00M | -0.6% | +1.1% | +11.0% | +8.9% | |
| Price | $79.71 | -38.1% | -50.6% | -55.6% | -54.7% | |
| PE Ratio | 13.21 | -38.9% | -55.0% | -67.4% | -72.2% | |
| TTM Revenue | $9.51B | +0.7% | +2.6% | +17.5% | +35.6% | |
| TTM EPS | $6.04 | +1.3% | +9.7% | +36.4% | +62.7% | |
| $3.57B | +0.3% | +5.0% | +24.6% | +43.8% | ||
| TTM Net Income | $2.64B | -0.0% | +5.8% | +27.8% | +49.2% |
TTM EBITDA Highs
| Period | High | Date | Current |
|---|---|---|---|
| 1Y | $4.06B | at high | |
| 3Y | $4.06B | at high | |
| 5Y | $4.06B | at high | |
| All | $4.06B | at high |
TTM EBITDA Lows
| Period | Low | Date | Current |
|---|---|---|---|
| 1Y | $3.89B | N/A | +4.3% |
| 3Y | $3.34B | N/A | +21.6% |
| 5Y | $2.93B | N/A | +38.8% |
| All | $201.00M | +1919.9% |
TTM EBITDA History
FAQ
What is the current TTM EBITDA of ZTS?
As of today, ZTS TTM EBITDA is $4.06B
What is ZTS TTM EBITDA most recent change?
ZTS TTM EBITDA was up +0.25% on March 31, 2026
What is 1-year change in ZTS TTM EBITDA?
ZTS TTM EBITDA is up +4.29% year-over-year
How far is ZTS TTM EBITDA from its all-time high?
ZTS TTM EBITDA is currently at its all-time high
How does ZTS TTM EBITDA rank versus sector peers?
ZTS TTM EBITDA is higher than 96.86% of companies in Healthcare sector
When is ZTS next earnings release?
The next earnings release for ZTS is on
EBITDA Formula
EBITDA = Net Income + + +
Data Sources & References
- ZTS Official Website www.zoetis.com
- Most Recent Annual Report (10-K) www.sec.gov/Archives/edgar/data/1555280/000155528026000011/0001555280-26-000011-index.htm
- ZTS Profile on Yahoo Finance finance.yahoo.com/quote/ZTS
- ZTS Profile on NASDAQ.com www.nasdaq.com/market-activity/stocks/zts